Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin.
Cantarovich
D
D
Service de Néphrologie et Immunologie Clinique Transplantation, Nantes University Hospital, France.
Hourmant
M
M
Dantal
J
J
Baatard
R
R
Le Mauff
B
B
Jacques
Y
Y
Paineau
J
J
Murat
A
A
Soulillou
J P
JP
D000206:Actuarial Analysis; D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007376:Interleukin-2 / Q000276:immunology*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology*; D011817:Rabbits; D016019:Survival Analysis; D013997:Time Factors
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007376:Interleukin-2; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone